David Oh
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Pros Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer | Phase 2 | 2019-10-30 |
| Completed | Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT Prostatic Neoplasms | Phase 2 | 2017-05-17 |